Transforming Tomorrow, Today
News & Updates from the National Brain Tumor Society
November 2013
Spotlight
SNO-ing: Gathering at the 4th Quadrennial Meeting of the World Federation of Neuro-Oncology

This year's 4th Quadrennial Meeting of the World Federation of Neuro-Oncology, hosted in conjunction with the Society for Neuro-Oncology’s (SNO) Scientific Meeting and Education Day (Nov. 21 - 24) in San Francisco, just concluded and the National Brain Tumor Society contingent has returned from an intense and exciting week of meetings with a wealth of new knowledge and connections.

The Annual SNO Meeting has significantly grown in size and importance. Through the convening of attendees from across the country and around the world, it allows us to not only hear the latest in brain tumor science, but to also have many productive meetings and individual discussions with advisors, biopharma industry representatives, and other patient advocacy groups to help to advance our programmatic agenda and mission efficiently and effectively. We are proud to support the work of this critical organization.

Read More
From the Blog
NOVEMBER 20, 2013
National Brain Tumor Society Announces the Defeat GBM Research Collaborative's Project Plans and Investigator Teams
National Brain Tumor Society recently announced further details on our Defeat GBM Research Collaborative, which aims to double the five-year survival rate of patients with glioblastoma multiforme (GBM) - the most common and deadliest form of brain cancer - in just five years. Details include the nature of the four (4) simultaneous and synergistic projects that make up the overall Initiative, as well as the partner institution and/or lead principal investigators responsible for each. And just last week the Initiative got its own dedicated website: www.DefeatGBM.org
Read More
NOVEMBER 12, 2013
Revisiting The Cancer Genome Atlas's GBM Project
When The Cancer Genome Atlas (TCGA) launched in 2006, it was a huge moment for cancer research. The National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) had come together to deliver researchers a better understanding of the molecular basis of cancer through the application of genome analysis and sequencing technologies. The [...]
Read More
see all blog posts
Research in the News
Biomaterial-Delivered Chemotherapy Could Provide Final Blow to Brain Tumors

Common Genetic Pathway Could Be Conduit to Pediatric Tumor Treatment

Imaging Studies May Predict Tumor Response to Anti-Angiogenic Drugs

CytRx Initiates Phase 2 Clinical Trial with Aldoxorubicin in Patients with Unresectable Glioblastoma Multiforme
Upcoming Events
Phoenix Brain Tumor Walk
Phoenix, AZ - Saturday, March 15 2014

 

Race For Hope Charlotte
Charlotte, NC - Saturday, March 22 2014

 

San Diego Brain Tumor Walk
San Diego, CA - Sunday, April 6 2014

 

Community Events
6th Annual Kickoff for Cancer
GARNET VALLEY, PA - SATURDAY, NOV 23 2013
Join us for a day of food, fun, and friends. This event is focused around a fieldgoal kicking competition. There will be a variety of children's games and entertainment as well.

 

Tie One On for Brain Cancer
DENVER, CO - SATURDAY, DEC 14 2013
Stay warm this winter and help fund a cure for brain cancer. Buy fabulous scarves, hats, blankets, and more!

 

Bella Notte
WASHINGTON, DC - THURSDAY, FEB 6 2014
A special cocktail reception to benefit the Brain Tumor Institute at Children's National Medical Center and National Brain Tumor Society.
View All Events
Connect facebook twitter youtube flickr donate Forward to a Friend
National Brain Tumor Society is fiercely committed to finding better treatments, and ultimately a cure, for people living with a brain tumor today and anyone who will be diagnosed tomorrow. This means effecting change in the system at all levels.
title Was this e-mail forwarded to you?
Subscribe today. Forward to a friend.
55 Chapel Street, Suite 200, Newton, MA 02458
617.924.9997 | Contact us | www.braintumor.org
Update email preferences or unsubscribe
© National Brain Tumor Society - All Rights Reserved.